Evidence map›Paper›PMID 25143800›Full record

ReviewOxidative medicine and cellular longevity2014

Oxidative stress and metabolic pathologies: from an adipocentric point of view.

Soazig Le Lay, Gilles Simard, Maria Carmen Martinez, Ramaroson Andriantsitohaina

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed, 3 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 3 syntheses or guidelines pooled it, 290 citations in OpenAlex.

  1. Pooled it
  2. A Review ofNutrients · 2019
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. The Pro-Metastatic Roles of ROS.Antioxidants (Basel, Switzerland) · 2026
    Review
  8. Article
  9. Obesity exacerbates giardiasis: metabolic, intestinal, and immune response in high-fat diet-fed gerbils.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Soazig Le LayINSERM UMR 1063, "Stress Oxydant et Pathologies Métaboliques", Institut de Biologie en Santé, 4 rue Larrey, 49933 Angers, France.
Gilles SimardINSERM UMR 1063, "Stress Oxydant et Pathologies Métaboliques", Institut de Biologie en Santé, 4 rue Larrey, 49933 Angers, France ; Department of Biochemistry, Université d'Angers, CHU Angers, 4 rue Larrey, 49933 Angers Cedex 9, France.ORCID 0000-0002-0223-1422
Maria Carmen MartinezINSERM UMR 1063, "Stress Oxydant et Pathologies Métaboliques", Institut de Biologie en Santé, 4 rue Larrey, 49933 Angers, France.
Ramaroson AndriantsitohainaINSERM UMR 1063, "Stress Oxydant et Pathologies Métaboliques", Institut de Biologie en Santé, 4 rue Larrey, 49933 Angers, France.
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative stress plays a pathological role in the development of various diseases including diabetes, atherosclerosis, or cancer. Systemic oxidative stress results from an imbalance between oxidants derivatives production and antioxidants defenses. Reactive oxygen species (ROS) are generally considered to be detrimental for health. However, evidences have been provided that they can act as second messengers in adaptative responses to stress. Obesity represents a major risk factor for deleterious associated pathologies such as type 2 diabetes, liver, and coronary heart diseases. Many evidences regarding obesity-induced oxidative stress accumulated over the past few years based on established correlations of biomarkers or end-products of free-radical-mediated oxidative stress with body mass index. The hypothesis that oxidative stress plays a significant role in the development of metabolic disorders, especially insulin-resistance state, is supported by several studies where treatments reducing ROS production reverse metabolic alterations, notably through improvement of insulin sensitivity, hyperlipidemia, or hepatic steatosis. In this review, we will develop the mechanistic links between oxidative stress generated by adipose tissue in the context of obesity and its impact on metabolic complications development. We will also attempt to discuss potential therapeutic approaches targeting obesity-associated oxidative stress in order to prevent associated-metabolic complications.

Indexed as

Oxidative StressAdipose Tissue, WhiteAntioxidantsHumansHyperglycemiaHyperlipidemiasNADPH OxidasesObesityReactive Oxygen SpeciesRenin-Angiotensin SystemAntioxidantsNADPH OxidasesReactive Oxygen Species

Identifiers

PMID25143800
PMCPMC4131099
OpenAlexW2139770322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.